New, highly experienced team members with a lot of passion, enthusiasm and drive have joined our growing Glycanostics team
We are happy to announce that our team is growing. Warm welcome to our R&D, marketing, business development, HR and office admin team members! We
Glycanostics have been awarded a Seal of Excellence under the EIC Transition scheme to continue with its development of diagnostic tests for breast, lung and pancreatic cancers
Applications that meet all the criteria but are not recommended for funding due to budget limitations will be awarded a Seal of Excellence to help
Glycanostics receives prestigious EIC Accelerator grant
Glycanostics has been selected as one of 65 innovative start-ups and SMEs out of more than 4,000 applicants to receive funding under the European Innovation Council
Glycanostics was successful on Crowdberry Investment Platform
Another important milestone achieved by the Glycanostics team! Via the Crowdberry Investment Platform, we presented our highly accurate diagnostic test to private investors in September
Glycanostics meets the President of the EC, Ms. Ursula von der Leyen
On Monday 21st June , our CEO Eva Kováčová (on the right) together with CSO Jan Tkac (on the left) had the great honour to introduce the company Glycanostics
Important step for Glycanostics with CBIM
Glycanostics and Crowdberry Investment Management took an important step towards achieving its vision. On Friday 7th May 2021 we signed an investment agreement to gain
Eva Kovacova joins Glycanostics as CEO as of January 2021
We are pleased to announce that Eva Kovacova joined Glycanostics as our CEO as of January 2021. Eva worked more than 18 years for some
A HIGHLY-PRESTIGIOUS AWARD FOR A GLYCANOSTICS CO-FOUNDER
This year, a well-established IT company from Slovakia ESET launched a prestigious ESET Science Award for exceptional scientists to increase the popularity of excellent scientists.
INTERNATIONAL PATENT APPLICATION NO. PCT/EP2019/057386
On 3rdOctober 2019, PCT application titled “Means and methods for glycoprofiling of aprotein” (applicant Glycanostics, inventors Tomas Bertok and Jan Tkac) waspublished under publication number WO
GLYCANOSTICS WINS NATIONAL ROUND OF CENTRAL EUROPEAN STARTUP AWARDS
With the unique, glycan-based technology and possible benefits forpatients, clinicians and society, Glycanostics was announced as a CESA awardwinner in two independent categories – Best
GLYCANOSTICS WINS HORIZON 2020 GRANT
After receiving the prestigious “Seal of Excellence” from the European Commission on October 23, 2018, Glycanostics’ next submission, to the Horizon 2020 Programme, won a € 50 000
GLYCANOSTICS RECEIVES THE PRESTIGIOUS HORIZON 2020 “SEAL OF EXCELLENCE”
The European Commission awarded Glycanostics the prestigious Seal of Excellence for its revolutionary prostate cancer early diagnostic tests. This project was submitted under the Horizon 2020 Programme
